Skip to main content
. 2012 Apr 18;5(2):242–246. doi: 10.3980/j.issn.2222-3959.2012.02.25

Table 1. General characteristic of studies included in the review.

Study Year Sample size Case/control Institution Subjects origin Phenotype of cases Mean age Male% Genotyping Method
Lau[16] 2006 163/232 National Yang-Ming University, Taipei Taiwan Neovascular AMD 76.1 81.8 PCR-RFLP
Chu[17] 2008 144/126 Peking Union Medical College Hospital Beijing Neovascular AMD 67.2 54.8 PCR-RFLP
Lin[19] 2008 133/180 China Medical University Hospital Taichung, Taiwan Early AMD NA NA Real-time PCR-based (melting curve analysis)
Ng[20] 2008 163/155 Chinese University of Hong Kong Hong Kong Neovascular AMD 74.3 50.3 Direct sequencing
Xu[21] 2008 121/132 Beijing Tongren Hospital Beijing Neovascular AMD 66.1 54.9 PCR-RFLP
Pei[22] 2009 123/130 Peking University People's Hospital Beijing Neovascular AMD 69.9 53.0 Direct sequencing
Gao[23] 2010 208/140 Beijing Tongren Hospital Beijing Soft drusen 57.5 44.8 PCR-RFLP
Liu[24] 2010 158/220 Sichuan Provincial People's Hospital Sichuan Mixed (neovascular/soft drusen) 64.2 54.6 Direct sequencing
80/220
Yang[25] 2010 109/150 Affiliated Hospital of Nantong University Nantong Neovascular AMD 64.8 46.7 PCR-RFLP
Dong[26] 2011 136/140 Qilu Hospital of Shandong University Shandong Neovascular AMD 70.4 59.0 PCR-RFLP

AMD= age-related macular degeneration; PCR= polymerase chain reaction; RFLP=restriction fragment length polymorphism. NA =not available.